CD8+ TSCMs are able to sustain for more than 25 years and to differentiate into TCM, TEM, and effector T cells.59, 60, 61 After re-stimulation, TSCM cells produce effector CD8+ T cells with high activity and low exhaustion markers, which leads to a powerful anti-tumor response.62 This evidence concerns the gene CD8A and neoplasm.